Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Use of the Probiotic, Lactobacillus Rhamnosus GG to Evaluate Colonization With Antimicrobial Resistant Bacteria in High Risk Patients

NCT01551186 is registered in ClinicalTrials.gov with Washington University School of Medicine as lead sponsor.

NCT NCT01551186
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01551186 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Use of the Probiotic, Lactobacillus Rhamnosus GG to Evaluate Colonization With Antimicrobial Resistant Bacteria in High Risk Patients
Lead sponsor
Washington University School of Medicine
Phase
Phase 4
Overall status
Completed
Start date
February 29, 2012
Completion date
December 31, 2013
Enrollment
103 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

infectious disease of digestive tract